Kang–Da Liu

1.5k total citations
41 papers, 1.2k citations indexed

About

Kang–Da Liu is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Kang–Da Liu has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 13 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Kang–Da Liu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Research and Treatments (6 papers). Kang–Da Liu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Cancer Research and Treatments (6 papers). Kang–Da Liu collaborates with scholars based in China, India and Germany. Kang–Da Liu's co-authors include Zhao–You Tang, Hui‐Chuan Sun, Jia Fan, Jian Zhou, Xin‐Da Zhou, Lun–Xiu Qin, Zeng‐Chen Ma, Zhiying Lin, Yinkun Liu and Sheng‐Long Ye and has published in prestigious journals such as Gastroenterology, Hepatology and Cancer.

In The Last Decade

Kang–Da Liu

41 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kang–Da Liu China 18 600 411 329 302 148 41 1.2k
Jing‐An Rui China 17 557 0.9× 315 0.8× 265 0.8× 238 0.8× 55 0.4× 36 1.1k
Akihiro Iemura Japan 13 439 0.7× 319 0.8× 214 0.7× 241 0.8× 138 0.9× 19 1.1k
Cristina Basilico Italy 17 669 1.1× 679 1.7× 148 0.4× 352 1.2× 231 1.6× 31 1.3k
Olivier Bluteau France 16 875 1.5× 336 0.8× 252 0.8× 376 1.2× 154 1.0× 28 1.6k
Shian‐Yang Peng Taiwan 13 808 1.3× 373 0.9× 418 1.3× 540 1.8× 124 0.8× 14 1.5k
Qiong Xue China 13 451 0.8× 207 0.5× 309 0.9× 258 0.9× 68 0.5× 22 872
Po‐Lin Lai Taiwan 20 933 1.6× 495 1.2× 485 1.5× 548 1.8× 151 1.0× 25 1.7k
Isabel Fiel United States 9 466 0.8× 575 1.4× 202 0.6× 203 0.7× 137 0.9× 12 1.3k
Aurélie Hérault France 12 808 1.3× 433 1.1× 394 1.2× 337 1.1× 164 1.1× 15 1.7k
Mary Matli United States 13 806 1.3× 155 0.4× 424 1.3× 431 1.4× 97 0.7× 20 1.3k

Countries citing papers authored by Kang–Da Liu

Since Specialization
Citations

This map shows the geographic impact of Kang–Da Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang–Da Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang–Da Liu more than expected).

Fields of papers citing papers by Kang–Da Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang–Da Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang–Da Liu. The network helps show where Kang–Da Liu may publish in the future.

Co-authorship network of co-authors of Kang–Da Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kang–Da Liu. A scholar is included among the top collaborators of Kang–Da Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang–Da Liu. Kang–Da Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiachu, Xin‐Rong Yang, Haixiang Sun, et al.. (2010). Up-regulation of Krüppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma. Gastroenterology. 139(6). 2146–2157.e12. 83 indexed citations
2.
Hu, Meiyu, Kang–Da Liu, Sarwat Fatima, et al.. (2009). Proteomic Identification of a Monoclonal Antibody Recognizing Caveolin-1 in Hepatocellular Carcinoma with Metastatic Potential. Protein and Peptide Letters. 16(5). 479–485. 3 indexed citations
3.
Xia, Xian, et al.. (2009). Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. Journal of Reproductive Immunology. 81(1). 89–96. 19 indexed citations
4.
Ke, Ai‐Wu, Guo‐Ming Shi, Jian Zhou, et al.. (2008). Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma #. Hepatology. 49(2). 491–503. 184 indexed citations
5.
Zhang, Yan, Meiyu Hu, Bihua Chen, et al.. (2006). [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].. PubMed. 14(7). 489–94. 3 indexed citations
6.
Zhang, Yan, Meiyu Hu, Bihua Chen, et al.. (2006). [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].. PubMed. 86(8). 530–5. 1 indexed citations
7.
Zhang, Yan, Meiyu Hu, Wei‐Zhong Wu, et al.. (2006). The membrane-cytoskeleton organizer ezrin is necessary for hepatocellular carcinoma cell growth and invasiveness. Journal of Cancer Research and Clinical Oncology. 132(11). 685–697. 37 indexed citations
8.
Tang, Zhao–You, Sheng‐Long Ye, Yinkun Liu, et al.. (2004). A decade?s studies on metastasis of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 130(4). 187–196. 386 indexed citations
9.
Wu, Wei‐Zhong, Hui‐Chuan Sun, Yanqin Gao, et al.. (2004). Reduction in p48-ISGFγ Levels Confers Resistance to Interferon-α<sub>2a</sub> in MHCC97 Cells. Oncology. 67(5-6). 428–440. 13 indexed citations
10.
Wang, Lu, Wei‐Zhong Wu, Hui‐Chuan Sun, et al.. (2003). Mechanism of Interferon Alpha on Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma After Curative Resection in Nude Mice. Journal of Gastrointestinal Surgery. 7(5). 587–594. 62 indexed citations
11.
He, Jin, Ge Zhou, Kang–Da Liu, & Xinyu Qin. (2002). Construction and Preliminary Screening of a Human Phage Single-Chain Antibody Library Associated with Gastric Cancer. Journal of Surgical Research. 102(2). 150–155. 4 indexed citations
12.
Zhou, Ge, et al.. (1997). Reconstruction and expression of chimeric anti-HBx antibody inEscherichia coli. Journal of Cancer Research and Clinical Oncology. 123(6). 325–330. 4 indexed citations
13.
Liao, Yong, et al.. (1997). Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studies. Journal of Cancer Research and Clinical Oncology. 123(1). 25–33. 17 indexed citations
14.
Tang, Zhao–You, et al.. (1996). Metastatic models of human liver cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Journal of Cancer Research and Clinical Oncology. 122(7). 397–402. 20 indexed citations
15.
Tang, Zhao–You, et al.. (1996). mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential. Journal of Cancer Research and Clinical Oncology. 122(1). 55–58. 4 indexed citations
16.
He, Bin, Zhao–You Tang, Kang–Da Liu, & Ge Zhou. (1996). Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype. Journal of Cancer Research and Clinical Oncology. 122(12). 763–766. 11 indexed citations
17.
Zeng, Zhao‐Chong, Zhao–You Tang, Kang–Da Liu, et al.. (1994). Human anti-(murine Ig) antibody responses in patients with hepatocellular carcinoma receiving intrahepatic arterial131I-labeled Hepama-1 mAb. Preliminary results and discussion. Cancer Immunology Immunotherapy. 39(5). 332–336. 11 indexed citations
18.
Zeng, Zhao‐Chong, et al.. (1993). Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results. Journal of Cancer Research and Clinical Oncology. 119(5). 257–259. 19 indexed citations
19.
Tang, Zhao–You, Ye‐Qin Yu, Xin‐Da Zhou, et al.. (1991). Cytoreduction and sequential resection: A hope for unresectable primary liver cancer. Journal of Surgical Oncology. 47(1). 27–31. 21 indexed citations
20.
Tang, Zhao–You, Ye‐Qin Yu, Zeng‐Chen Ma, et al.. (1989). Conversion of surgically verified unresectable to resectable hepatocellular carcinoma. Chinese Journal of Cancer Research. 1(3). 41–47. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing‐An Rui Breakdown of academic impact, for papers by Akihiro Iemura Breakdown of academic impact, for papers by Cristina Basilico Breakdown of academic impact, for papers by Olivier Bluteau Breakdown of academic impact, for papers by Shian‐Yang Peng Breakdown of academic impact, for papers by Qiong Xue Breakdown of academic impact, for papers by Po‐Lin Lai Breakdown of academic impact, for papers by Isabel Fiel Breakdown of academic impact, for papers by Aurélie Hérault Breakdown of academic impact, for papers by Mary Matli
Rankless by CCL
2026